Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.

  title={Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.},
  author={Moncef Slaoui and Matthew Hepburn},
  journal={The New England journal of medicine},
Operation Warp Speed’s Strategy and Approach The public–private initiative Operation Warp Speed aims to deliver tens of millions of doses of an FDA-approved SARS-CoV-2 vaccine beginning at the end ... 
Operation Warp Speed: implications for global vaccine security
  • Jerome H Peter Carolina Onder J Peter Sarah Mayda Mazen G Kim Hotez Batista Ergonul Figueroa Gilbert Gursel , Jerome H. Kim, +16 authors M. Bottazzi
  • Medicine
  • The Lancet Global Health
  • 2021
Several global efforts are underway to develop COVID-19 vaccines, and interim analyses from phase 3 clinical testing have been announced by nine organisations: Pfizer, the Gamaleya ResearchExpand
SARS-CoV-2 vaccine development, access, and equity
  • Jerome H. Kim
  • Medicine, Business
  • The Journal of experimental medicine
  • 2020
A COVID-19 vaccine must first be proven to be safe and effective, but making billions of doses of high quality vaccine and using it equitably and accessibly may present an equal if not greaterExpand
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
The current status of COVID-19 vaccine development is discussed and a perspective for how partnership and preparedness can be better utilized in response to future public-health pandemic emergencies is provided. Expand
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
Despite successful vaccine development for COVID-19, the world will face a whole new set of challenges including scale-up manufacturing, cold-chain logistics, long-term safety, and low vaccine acceptance. Expand
What Health Care Can Learn from Operation Warp Speed
The “RAPID” process used in Operation Warp Speed achieved amazing results at a time of great need.
SARS-CoV-2 vaccines, where do we stand?
Vaccination against the SARS-CoV-2, the virus responsible for the Covid-19 pandemic, represents a major infection control strategy in the absence of effective treatment of the disease to date.Expand
The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
Ending the COVID-19 pandemic cannot rest on the promise of vaccination alone – it will require a continued, robust and multi-faceted approach to disease treatment and prevention. Expand
Helpful Lessons and Cautionary Tales: How Should COVID-19 Drug Development and Access Inform Approaches to Non-Pandemic Diseases?
Abstract After witnessing extraordinary scientific and regulatory efforts to speed development of and access to new COVID-19 interventions, patients facing other serious diseases have begun to askExpand
COVID-19 Vaccines and the Case for a New Global Health Diplomacy
OVID-19 is the first time in recent medical history where an effective vaccine would have imminent, near universal demand. This has no doubt provided a massive impetus to risk taking in the vaccinesExpand
COVID-19 vaccine development: a pediatric perspective
In light of the safety and immunogenicity results from recent adult COVID-19 vaccine clinical trials, children should have the opportunity to be included in clinical trials in parallel to ongoing adult phase 3 clinical Trials in a manner that is careful, methodical and transparent. Expand